Fund Name | Location |
Arkansas Economic Development Commission | Arkansas, Little Rock, United States |
Athena Technology Investors | - |
Attractor Investment Management | Seattle, United States, Washington |
Canadian Cancer Society | Canada, Ontario, Toronto |
Cassia Investments | China, Hong Kong, Hong Kong Island |
Dividend Capital | - |
Extream Ventures | Central, Central Region, Singapore |
GSM | - |
Innovate Angel Funds | College Station, Texas, United States |
JANVEST Capital Partners | New York, New York, United States |
K2 | Bellevue, United States, Washington |
Kstart Capital | - |
Manulife Financial | Canada, Ontario, Toronto |
MegaThrust Capital Berhad | - |
Nanjing Daofeng Investment | - |
TIE Toronto | Canada, Ontario, Toronto |
Tuscon Ventures | Arizona, Tucson, United States |
Veritas Capital | New York, New York, United States |
Voltage Japan | Japan, Tokyo |
Wheelhouse | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Clover Biopharmaceuticals | $47M | 27 Nov 2019 | Qingyang District, Sichuan, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Clover Biopharmaceuticals | $47M | 27 Nov 2019 | Qingyang District, Sichuan, China |